Epidermolysis Bullosa News (@epibullosanews) 's Twitter Profile
Epidermolysis Bullosa News

@epibullosanews

We exist to bring you science, research and clinical news about Epidermolysis Bullosa. We are a free digital publication dedicated to the patient community.

ID: 1303643312642043904

linkhttps://epidermolysisbullosanews.com/ calendar_today09-09-2020 10:36:07

425 Tweet

226 Followers

12 Following

Epidermolysis Bullosa News (@epibullosanews) 's Twitter Profile Photo

The first patient has been dosed in a clinical trial evaluating Aegle Therapeutics' AGLE-102, an investigational topical treatment for DEB. buff.ly/4dMzTWw

The first patient has been dosed in a clinical trial evaluating Aegle Therapeutics' AGLE-102, an investigational topical treatment for DEB. buff.ly/4dMzTWw